| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Orifarm Generics A/S, STADA Nordic ApS, Viatris ApS, +7 | 102,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Sandoz A/S, +7 | 46,2 mio. kr. (samlet) | 27.10.2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, +2 | 59,2 mio. kr. (samlet) | 26.10.2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS | 75,2 mio. kr. (samlet) | 22.10.2026 |
| Amgros 2027 2.203.b | Amgros I/S | Pfizer ApS, Abacus Medicine A/S, 2care4 ApS, Orifarm A/S | 26,7 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.202.a | Amgros I/S | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33,9 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, +6 | 148,1 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Abacus Medicine A/S, Chiesi Pharma AB, Paranova Danmark A/S, +1 | 33,6 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Aguettant Nordic ApS, Zentiva Denmark ApS, Øresund Pharma ApS, GE Healthcare A/S, +4 | 73,5 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.201.a | Amgros I/S | 2care4 ApS, LEO Pharma A/S, Abacus Medicine A/S, Viatris ApS, Octapharma Nordic AB, CSL Behring AB, +2 | 101,4 mio. kr. (samlet) | 15.10.2026 |
| Amgros 2027 1.1171.a | Amgros I/S | Bristol-Myers Squibb Denmark. Filial Af Bristol-Myers Squibb AB. Sverige, 2care4 ApS | 300,6 mio. kr. (samlet) | 30.9.2026 |
| Amgros 2027 1.1051.b | Amgros I/S | 2care4 ApS, Orifarm A/S, Roche Pharmaceuticals A/S | 254 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, +3 | 704 mio. kr. (samlet) | 23.9.2026 |
| Amgros 2026 1.606.a | Amgros I/S | CampusPharma AB, Accord Healthcare AB, 2care4 ApS | 32,5 mio. kr. (samlet) | 9.7.2026 |
| Amgros 2027 1.1577.a | Amgros I/S | 2care4 ApS | 60,4 mio. kr. | 7.7.2026 |
| Amgros 2026 1.353.b | Amgros I/S | Pfizer ApS, Orifarm A/S, Sandoz A/S, 2care4 ApS, Biogen (Denmark) A/S, Celltrion Healthcare Denmark ApS, +10 | 2,3 mia. kr. (samlet) | 13.3.2026 |
| Amgros 2026 2.703.b | Amgros I/S | 2care4 Generics ApS, Paranova Danmark A/S, Orifarm A/S, Abcur AB, 2care4 ApS, Abacus Medicine A/S, +3 | 66 mio. kr. (samlet) | 17.2.2026 |
| Amgros 2026 1.295.a | Amgros I/S | Sciensus International B.V., Nordic Prime ApS, Orifarm A/S, 2care4 ApS, Ctruz ApS, Medartuum AB, +2 | 46,8 mio. kr. (samlet) | 29.1.2026 |
| Amgros 2026 2.1306.b | Amgros I/S | MSD Danmark ApS, EQL Pharma AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, 2care4 ApS, Abcur AB, Abacus Medicine A/S, +1 | 26 mio. kr. (samlet) | 26.1.2026 |
| Amgros 2026 1.450.b | Amgros I/S | Orifarm A/S, Abacus Medicine A/S, Astellas Pharma A/S, 2care4 ApS, Medice Arzneimittel Pütter GmbH & Co KG | 73 mio. kr. (samlet) | 24.12.2025 |
| Amgros 2026 1.601.a | Amgros I/S | 2care4 ApS, Hameln Pharma ApS, Abacus Medicine A/S, MSD Danmark ApS, Accord Healthcare AB, Unimedic Pharma AB, +5 | 331,8 mio. kr. (samlet) | 17.11.2025 |
| Amgros 2026 1.1053.b | Amgros I/S | Biocon, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare Denmark ApS, Pfizer ApS, Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, +2 | 948,6 mio. kr. (samlet) | 12.11.2025 |
| Amgros 2026 1.1201.a | Amgros I/S | 2care4 ApS, Macure Pharma ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Unimedic Pharma AB, Navamedic AB, +7 | 358,5 mio. kr. (samlet) | 10.11.2025 |
| Amgros 2026 2.1390.b | Amgros I/S | Viatris ApS, EQL Pharma AB, Orifarm Generics A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, +6 | 23,9 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 2.1302.b | Amgros I/S | Panpharma Nordic AS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, EQL Pharma AB, Sandoz A/S, Navamedic AB, Abcur AB, +7 | 162 mio. kr. (samlet) | 3.11.2025 |
| Amgros 2026 1.603.a | Amgros I/S | 2care4 Generics ApS, Haleon Denmark ApS, Teva Denmark A/S, EQL Pharma AB, 2care4 ApS | 7,9 mio. kr. (samlet) | 31.10.2025 |
| Amgros 2026 1.615.b | Amgros I/S | Desitin Pharma A/S, Sanofi A/S, Life Medical ApS, STADA Nordic ApS, Stragen Nordic A/S, Sun Pharmaceuticals Germany GmbH, +10 | 48,2 mio. kr. (samlet) | 31.10.2025 |
| Amgros 2026 1.1203.a | Amgros I/S | LEO Pharma A/S, Mundipharma A/S, Pharmanovia A/S, Øresund Pharma ApS, Orifarm Generics A/S, Paranova Danmark A/S, +5 | 368,5 mio. kr. (samlet) | 30.10.2025 |